ArticleJournal of translational medicine2023

ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy.

Tianxiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.